Cell and Gene Therapies

Capability

TIA brings together five leading cell and gene therapy development

and manufacturing facilities in Australia to facilitate the translation

from discovery to clinical benefit, ensuring that manufacturing occurs

in compliance with regulations and that products entering clinical

trials are of a sufficiently high standard.

TIA has partnered with CCRM Australia, an organisation that accelerates the commercialisation of Australian regenerative medicine therapies and related technologies. CCRM achieves this through engagement and fostering local and international collaboration between industry, clinicians and academia.

Capabilities/Services offered  >

Cell and Tissue Therapies WA 

 

Q-Gen Cell Therapeutics 

QGEN.jpg
Capabilities/Services offered  >
Capabilities/Services offered  >

Cell & Molecular Therapies, RPA Hospital

RPAH crest.JPG
Capabilities/Services offered  >

Sydney Cell and Gene Therapy 

 
Capabilities/Services offered  >

Centre of Excellence in Cellular Immunotherapy

PETERMAC.jpg
 

Contact us

+61 (07) 3735 4433

Subscribe to our newsletter to stay up-to-date on the latest news and events